Updated APLAR consensus statements on care for patients with rheumatic diseases during the COVID-19 pandemic.
Lai Shan TamYoshiya TanakaRohini HandaZhan-Guo LiJose Paulo LorenzoWorawit LouthrenooCatherine HillKevin PilePhilip C RobinsonLeonila F DansLi-Yang HsuSang-Min LeeJiacai ChoA T M Tanveer HasanBabur SalimSaba SamreenSyahrul Sazliyana ShaharirPriscilla WongJeffrey ChauDebashish DandaSyed Atiqul HaqPublished in: International journal of rheumatic diseases (2021)
Available evidence primarily from descriptive research supported new recommendations for aspects of RMD care not covered in the previous document, particularly with regard to risk factors for complicated COVID-19 in RMD patients, modifications to RMD treatment regimens in the context of the pandemic, and COVID-19 vaccination in patients with RMD.
Keyphrases
- coronavirus disease
- sars cov
- healthcare
- end stage renal disease
- palliative care
- ejection fraction
- newly diagnosed
- quality improvement
- chronic kidney disease
- clinical practice
- pain management
- respiratory syndrome coronavirus
- prognostic factors
- peritoneal dialysis
- combination therapy
- health insurance
- patient reported